Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

EBioMedicine·2026
Same author

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Scientific reports·2026
Same author

Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responses.

EBioMedicine·2026
Same author

IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Cancer immunology research·2026
Same author

Efferocytic remodelling of pancreatic islet macrophages by limited β-cell death.

Nature·2025
Same author

Dendritic cells function beyond antigen presentation.

Cancer cell·2025

Related Experiment Video

Updated: Jun 4, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Targeting human dendritic cell subsets for improved vaccines.

Hideki Ueno1, Eynav Klechevsky, Nathalie Schmitt

  • 1Baylor Institute for Immunology Research, Baylor Research Institute, 3434 Live Oak, Dallas, TX 75204, USA. hidekiu@baylorhealth.edu

Seminars in Immunology
|February 1, 2011
PubMed
Summary
This summary is machine-generated.

Dendritic cells (DCs) are key regulators of adaptive immunity. Recent research reveals distinct human DC subsets with diverse functions, offering new avenues for medical applications and targeted therapies.

More Related Videos

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

Related Experiment Videos

Last Updated: Jun 4, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Dendritic cells (DCs) were identified in 1973 as crucial regulators of adaptive immunity.
  • Recent studies reveal diverse human DC subsets with distinct localization, phenotypes, and functions.

Purpose of the Study:

  • To review human DC subsets.
  • To discuss their medical applications.
  • To focus on DC targeting strategies.

Main Methods:

  • Literature review of recent studies on dendritic cell biology.
  • Analysis of human DC subset characteristics.
  • Examination of current and potential medical applications.

Main Results:

  • Human DCs comprise multiple subsets with specialized roles in immune responses.
  • Understanding these subsets provides a framework for advancing human health.
  • Targeting specific DC subsets holds promise for therapeutic interventions.

Conclusions:

  • The diverse nature of human dendritic cell subsets is central to their immunoregulatory functions.
  • Targeting dendritic cells offers a promising strategy for developing novel medical treatments.
  • Further research into DC subsets can significantly improve human health outcomes.